首页 > 最新文献

New Microbiologica最新文献

英文 中文
Epidemiology and molecular characterization of respiratory viruses at the end of COVID-19 pandemic in Lombardy, Northern Italy. 意大利北部伦巴第 COVID-19 大流行结束时呼吸道病毒的流行病学和分子特征。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Leonardo Sclavi, Marta Bertelli, Serena Messali, Arnaldo Caruso, Francesca Caccuri

The COVID-19 pandemic forced the adoption of non-pharmaceutical interventions (NPIs) which influenced the circulation of other respiratory pathogens, such as Influenza virus (FLU), Parainfluenza virus (PIV), Respiratory Syncytial virus (RSV), Rhinovirus (RV), Enterovirus (EV), Adenovirus (AdV), Human Metapneumovirus (hMPV), and Human Coronavirus (CoV). The aim of the current study was to investigate how, with the end of the pandemic, the withdrawal of the NPIs impacted on the circulation and distribution of common respiratory viruses. The analyzed samples were collected from June 2021 to March 2023 (post-pandemic period) and compared to ones from the pandemic period. Nucleic acid detection of all respiratory viruses was performed by multiplex real time Polymerase Chain Reaction (PCR) and sequencing was conducted by Next Generation Sequencing (NGS) technique. Our analysis shows that the NPIs adopted against SARS-CoV-2 were also effective in controlling the spread of other respiratory viruses. Moreover, we documented how RV/EVs were the most commonly identified species, with the more abundant strains represented by Coxsackievirus (CV)-A/B and RV-A/C. RV/EVs were also detected in some co-infection cases; in particular, the majority of co-infections concerned CV-B/RV-A, CV-B/ECHO. Given the pandemic potential of respiratory viruses, accurate molecular screening is essential for a proper surveillance and prevention strategy.

COVID-19 大流行迫使人们采用非药物干预措施(NPIs),这影响了其他呼吸道病原体的流通,如流感病毒(FLU)、副流感病毒(PIV)、呼吸道合胞病毒(RSV)、鼻病毒(RV)、肠病毒(EV)、腺病毒(AdV)、人类肺炎病毒(hMPV)和人类冠状病毒(CoV)。本研究的目的是调查随着大流行的结束,NPIs 的撤销对常见呼吸道病毒的流通和分布有何影响。所分析的样本收集于 2021 年 6 月至 2023 年 3 月(大流行后),并与大流行期间的样本进行了比较。所有呼吸道病毒的核酸检测均通过多重实时聚合酶链反应(PCR)进行,测序则通过新一代测序(NGS)技术进行。我们的分析表明,针对 SARS-CoV-2 采用的 NPI 也能有效控制其他呼吸道病毒的传播。此外,我们还记录了 RV/EVs 是如何成为最常被识别的病毒种类,其中较多的毒株是柯萨奇病毒(CV)-A/B 和 RV-A/C。在一些合并感染病例中也检测到了 RV/EV;特别是,大多数合并感染涉及 CV-B/RV-A、CV-B/ECHO。鉴于呼吸道病毒具有大流行的潜力,准确的分子筛查对于适当的监测和预防策略至关重要。
{"title":"Epidemiology and molecular characterization of respiratory viruses at the end of COVID-19 pandemic in Lombardy, Northern Italy.","authors":"Leonardo Sclavi, Marta Bertelli, Serena Messali, Arnaldo Caruso, Francesca Caccuri","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The COVID-19 pandemic forced the adoption of non-pharmaceutical interventions (NPIs) which influenced the circulation of other respiratory pathogens, such as Influenza virus (FLU), Parainfluenza virus (PIV), Respiratory Syncytial virus (RSV), Rhinovirus (RV), Enterovirus (EV), Adenovirus (AdV), Human Metapneumovirus (hMPV), and Human Coronavirus (CoV). The aim of the current study was to investigate how, with the end of the pandemic, the withdrawal of the NPIs impacted on the circulation and distribution of common respiratory viruses. The analyzed samples were collected from June 2021 to March 2023 (post-pandemic period) and compared to ones from the pandemic period. Nucleic acid detection of all respiratory viruses was performed by multiplex real time Polymerase Chain Reaction (PCR) and sequencing was conducted by Next Generation Sequencing (NGS) technique. Our analysis shows that the NPIs adopted against SARS-CoV-2 were also effective in controlling the spread of other respiratory viruses. Moreover, we documented how RV/EVs were the most commonly identified species, with the more abundant strains represented by Coxsackievirus (CV)-A/B and RV-A/C. RV/EVs were also detected in some co-infection cases; in particular, the majority of co-infections concerned CV-B/RV-A, CV-B/ECHO. Given the pandemic potential of respiratory viruses, accurate molecular screening is essential for a proper surveillance and prevention strategy.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"80-87"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lamivudine plus dolutegravir as a switch strategy in children: three case reports. 拉米夫定加多鲁曲韦作为儿童的转换策略:三份病例报告。
IF 1.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Laura Labate, Claudia Bartalucci, Lucia Taramasso, Giorgia Brucci, Antonio Vena, Matteo Bassetti, Antonio Di Biagio

Lamivudine (3TC)/dolutegravir (DTG) single tablet regimen (STR) has shown long-term efficacy and tolerability in people living with HIV (PLWH). Dolutegravir has been approved for use in children, while data on the efficacy of 3TC plus DTG in maintaining virological suppression in this population are still under evaluation. In this case series, we describe three children with perinatally acquired HIV who maintained virological suppression after switching antiretroviral therapy to DTG/3TC. We present three case reports of three children enrolled in the Italian Register for HIV Infection in Children: a 9-year-old boy, a 10-year-old girl, and a 2-year-old girl with perinatally acquired HIV who immediately started antiretroviral therapy with a three-drug regimen upon diagnosis, which occurred at delivery, after 6 months of life, and after 2 years of life, respectively. They achieved and maintain virological suppression after 1, 6, and 7 months of therapy, respectively; then a switch strategy was performed with a two-drug regimen with DTG/3TC STR at the age of 7 years for the first child and at the age of 9 years for the second, while the third was switched to a DTG plus 3TC not STR, owing to weight requirements, at the age of 2 years and 10 months. All children maintained virological suppression at last follow-up visit (January 2024), showing an excellent growth curve and maintaining good adherence and tolerability to DTG plus 3TC. A two-drug regimen with DTG/3TC demonstrated efficacy in maintaining virological suppression in a switch strategy in these children, with important advantages such as better tolerability and comfort of taking a single tablet once daily.

拉米夫定(3TC)/多罗替拉韦(DTG)单片剂疗法(STR)在艾滋病毒感染者(PLWH)中显示出长期疗效和耐受性。多罗替拉韦已获准用于儿童,而 3TC 加 DTG 在儿童中维持病毒抑制的疗效数据仍在评估中。在本系列病例中,我们描述了三名围产期感染艾滋病病毒的儿童在改用 DTG/3TC 抗逆转录病毒疗法后维持病毒学抑制的情况。我们报告了意大利儿童艾滋病病毒感染登记处登记的三名儿童的三个病例:一名 9 岁男孩、一名 10 岁女孩和一名 2 岁女孩患有围产期感染的艾滋病病毒,他们分别在分娩时、出生 6 个月后和出生 2 年后确诊,并立即开始接受三药联合抗逆转录病毒治疗。他们分别在治疗 1 个月、6 个月和 7 个月后达到并维持病毒抑制;然后,第一个孩子在 7 岁时和第二个孩子在 9 岁时分别改用 DTG/3TC STR 双药方案,第三个孩子则在 2 岁 10 个月时因体重需要改用 DTG 加 3TC 而非 STR 方案。所有患儿在最后一次随访(2024 年 1 月)时都保持了病毒抑制,显示出良好的生长曲线,并对 DTG 加 3TC 保持良好的依从性和耐受性。DTG/3TC双药治疗方案在这些儿童的转换策略中显示出了维持病毒抑制的疗效,而且具有更好的耐受性和每天服用一次单片药片的舒适性等重要优势。
{"title":"Lamivudine plus dolutegravir as a switch strategy in children: three case reports.","authors":"Laura Labate, Claudia Bartalucci, Lucia Taramasso, Giorgia Brucci, Antonio Vena, Matteo Bassetti, Antonio Di Biagio","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lamivudine (3TC)/dolutegravir (DTG) single tablet regimen (STR) has shown long-term efficacy and tolerability in people living with HIV (PLWH). Dolutegravir has been approved for use in children, while data on the efficacy of 3TC plus DTG in maintaining virological suppression in this population are still under evaluation. In this case series, we describe three children with perinatally acquired HIV who maintained virological suppression after switching antiretroviral therapy to DTG/3TC. We present three case reports of three children enrolled in the Italian Register for HIV Infection in Children: a 9-year-old boy, a 10-year-old girl, and a 2-year-old girl with perinatally acquired HIV who immediately started antiretroviral therapy with a three-drug regimen upon diagnosis, which occurred at delivery, after 6 months of life, and after 2 years of life, respectively. They achieved and maintain virological suppression after 1, 6, and 7 months of therapy, respectively; then a switch strategy was performed with a two-drug regimen with DTG/3TC STR at the age of 7 years for the first child and at the age of 9 years for the second, while the third was switched to a DTG plus 3TC not STR, owing to weight requirements, at the age of 2 years and 10 months. All children maintained virological suppression at last follow-up visit (January 2024), showing an excellent growth curve and maintaining good adherence and tolerability to DTG plus 3TC. A two-drug regimen with DTG/3TC demonstrated efficacy in maintaining virological suppression in a switch strategy in these children, with important advantages such as better tolerability and comfort of taking a single tablet once daily.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"111-115"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Risk Human Papilloma Virus Genotype Distribution and Correlation with Cervical Cytomorphological Data in Turkish and Immigrant Women in Mersin Province. 梅尔辛省土耳其妇女和移民妇女的高危人类乳头瘤病毒基因型分布及其与宫颈细胞形态学数据的相关性
IF 1.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Murat Yaman, Hacer Ece Arslan Özcan, Ayfer Bakir

Human papilloma virus (HPV) is the most common sexually transmitted viral agent in the world and the most common cause of cervical cancer. HPV prevalence and genotype distribution vary by region and demographic data. In a province in the south of Turkey that constantly receives immigration, we aimed to determine the prevalence of high-risk HPV (HR-HPV) genotypes, evaluate the compatibility between cervical Pap smear cytology results patients and HR-HPVs, and make an up-to-date contribution to the elucidation of epidemiological data. In this single-centre study, a total of 12,641 women aged 18 and over were evaluated retrospectively from January 2019 to July 2022. HPV detection and genotyping were analysed by the PCR method. Bethesda scoring was used for Pap smear cytological evaluation. The overall prevalence of HR-HPV was 12.6% (12.7% in Turkish women, 11.2% in foreign women). Among the typed HPVs that were detected, HPV-16 (31%) was found first, followed by HPV-18 (8%). The prevalence of HR-HPV was higher in women with abnormal cytology (977/1762, 55.4%) than in women with normal cytology (620/10879, 5.7%) (p<0.001). Turkey doesn't yet have a national HPV immunisation program. We think that determining the specific regional frequency of other HR-HPVs separately will be useful in the follow-up of the natural course of the type-specific infection and in vaccine studies in the future.

人乳头瘤病毒(HPV)是世界上最常见的性传播病毒,也是宫颈癌最常见的病因。HPV 的流行率和基因型分布因地区和人口数据而异。在土耳其南部一个不断接收移民的省份,我们旨在确定高危 HPV(HR-HPV)基因型的流行率,评估宫颈巴氏涂片细胞学检查结果患者与 HR-HPV 之间的匹配性,并为阐明流行病学数据做出最新贡献。在这项单中心研究中,从 2019 年 1 月到 2022 年 7 月,共对 12641 名 18 岁及以上女性进行了回顾性评估。HPV检测和基因分型采用PCR方法进行分析。巴氏涂片细胞学评估采用贝塞斯达评分法。HR-HPV的总患病率为12.6%(土耳其妇女为12.7%,外国妇女为11.2%)。在检测到的分型 HPV 中,首先发现的是 HPV-16(31%),其次是 HPV-18(8%)。细胞学检查异常的妇女(977/1762,55.4%)的 HR-HPV 感染率高于细胞学检查正常的妇女(620/10879,5.7%)(p
{"title":"High-Risk Human Papilloma Virus Genotype Distribution and Correlation with Cervical Cytomorphological Data in Turkish and Immigrant Women in Mersin Province.","authors":"Murat Yaman, Hacer Ece Arslan Özcan, Ayfer Bakir","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Human papilloma virus (HPV) is the most common sexually transmitted viral agent in the world and the most common cause of cervical cancer. HPV prevalence and genotype distribution vary by region and demographic data. In a province in the south of Turkey that constantly receives immigration, we aimed to determine the prevalence of high-risk HPV (HR-HPV) genotypes, evaluate the compatibility between cervical Pap smear cytology results patients and HR-HPVs, and make an up-to-date contribution to the elucidation of epidemiological data. In this single-centre study, a total of 12,641 women aged 18 and over were evaluated retrospectively from January 2019 to July 2022. HPV detection and genotyping were analysed by the PCR method. Bethesda scoring was used for Pap smear cytological evaluation. The overall prevalence of HR-HPV was 12.6% (12.7% in Turkish women, 11.2% in foreign women). Among the typed HPVs that were detected, HPV-16 (31%) was found first, followed by HPV-18 (8%). The prevalence of HR-HPV was higher in women with abnormal cytology (977/1762, 55.4%) than in women with normal cytology (620/10879, 5.7%) (p<0.001). Turkey doesn't yet have a national HPV immunisation program. We think that determining the specific regional frequency of other HR-HPVs separately will be useful in the follow-up of the natural course of the type-specific infection and in vaccine studies in the future.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"88-97"},"PeriodicalIF":1.5,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long COVID: lights and shadows on the clinical characterization of this emerging pathology. 长COVID:这一新兴病理临床特征的光与影。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Viola Cogliandro, Paolo Bonfanti

More than 800 million individuals have contracted SARSCOV2 infection worldwide. It was estimated that almost 10-20% of these might suffer from Long COVID. It is a multisystemic syndrome, which negatively affects the quality of life with a significant burden of health loss compared to COVID negative individuals. Moreover, the risk of sequelae still remains high at 2 years in both nonhospitalized and hospitalized individuals. This review summarizes studies regarding long COVID and clarifies the definitions, the risk factors and the management of this syndrome. Finally, it delves into the most frequent long-term outcomes, especially postural orthostatic tachycardia syndrome" (POTS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), brain fog, and their therapeutical possibilities.

全球已有超过 8 亿人感染了 SARSCOV2。据估计,其中近 10-20% 的人可能患有长 COVID。这是一种多系统综合征,与 COVID 阴性患者相比,它对生活质量造成负面影响,并带来巨大的健康损失。此外,无论是非住院患者还是住院患者,2 年后出现后遗症的风险仍然很高。本综述总结了有关长 COVID 的研究,并阐明了该综合征的定义、风险因素和管理方法。最后,它深入探讨了最常见的长期后遗症,尤其是体位性正位性心动过速综合征(POTS)、肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)、脑雾及其治疗可能性。
{"title":"Long COVID: lights and shadows on the clinical characterization of this emerging pathology.","authors":"Viola Cogliandro, Paolo Bonfanti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>More than 800 million individuals have contracted SARSCOV2 infection worldwide. It was estimated that almost 10-20% of these might suffer from Long COVID. It is a multisystemic syndrome, which negatively affects the quality of life with a significant burden of health loss compared to COVID negative individuals. Moreover, the risk of sequelae still remains high at 2 years in both nonhospitalized and hospitalized individuals. This review summarizes studies regarding long COVID and clarifies the definitions, the risk factors and the management of this syndrome. Finally, it delves into the most frequent long-term outcomes, especially postural orthostatic tachycardia syndrome\" (POTS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), brain fog, and their therapeutical possibilities.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"15-27"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro analysis of Porcine Endogenous Retroviruses in different pig cell types. 猪内源性逆转录病毒在不同猪细胞类型中的体外分析。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Andrea Cacciamali, Silvia Dotti, Riccardo Villa

The shortage of organs for human transplantation is a topic of extreme interest, and xenotransplantation with porcine organs has been recognized as a promising solution. However, the potential spillover linked to infectious agents present in pigs remains a concern. Among these, Pig Endogenous Retroviruses (PERVs), whose proviral DNAs are integrated in the genome of all pig breeds, represent an extremely important biological risk. This study aims to evaluate PERVs distribution in several swine cell lines and samples of domestic and feral pigs. Moreover, the capacity of PERVs to infect human and non-human primate cells and to integrate in the cellular genome was tested by Real-Time PCR and by Reverse Transcriptase assay. Results indicated a widespread diffusion of PERVs both in cell lines and samples analysed: the viral genome was found in all the established cell lines, in 40% of the primary cell lines and in 60% of the tissue samples tested. The assays indicated that the virus can be transmitted from porcine to human cells: in the specific case, infected NSK and NPTr cells allow passage to human 293 and MRC-5 cells with active production of the virus demonstrable via PCR and RT assay. In light of these aspects and also the lack of studies on PERVs, it appears clear that there are still many questions to be clarified, also by means of future studies, before xenotransplantation can be considered microbiologically safe.

用于人体移植手术的器官短缺是一个极受关注的话题,而猪器官异种移植已被认为是一种很有前景的解决方案。然而,与猪体内存在的传染性病原体有关的潜在溢出效应仍然令人担忧。其中,猪内源性逆转录病毒(PERVs)的前病毒 DNA 已整合到所有猪种的基因组中,具有极其重要的生物学风险。本研究旨在评估 PERVs 在几种猪细胞系以及家猪和野猪样本中的分布情况。此外,还通过 Real-Time PCR 和逆转录酶分析法检测了 PERVs 感染人类和非人灵长类细胞以及整合到细胞基因组的能力。结果表明,PERVs 在细胞系和分析样本中广泛扩散:在所有已建立的细胞系、40% 的原代细胞系和 60% 的测试组织样本中都发现了病毒基因组。检测结果表明,病毒可从猪细胞传播到人体细胞:在特定情况下,受感染的 NSK 和 NPTr 细胞可通过人 293 和 MRC-5 细胞,通过 PCR 和 RT 检测可证明病毒的活性产生。鉴于这些方面以及缺乏对 PERVs 的研究,在异种移植被视为微生物安全之前,显然还有许多问题需要澄清,也需要通过未来的研究来解决。
{"title":"In vitro analysis of Porcine Endogenous Retroviruses in different pig cell types.","authors":"Andrea Cacciamali, Silvia Dotti, Riccardo Villa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The shortage of organs for human transplantation is a topic of extreme interest, and xenotransplantation with porcine organs has been recognized as a promising solution. However, the potential spillover linked to infectious agents present in pigs remains a concern. Among these, Pig Endogenous Retroviruses (PERVs), whose proviral DNAs are integrated in the genome of all pig breeds, represent an extremely important biological risk. This study aims to evaluate PERVs distribution in several swine cell lines and samples of domestic and feral pigs. Moreover, the capacity of PERVs to infect human and non-human primate cells and to integrate in the cellular genome was tested by Real-Time PCR and by Reverse Transcriptase assay. Results indicated a widespread diffusion of PERVs both in cell lines and samples analysed: the viral genome was found in all the established cell lines, in 40% of the primary cell lines and in 60% of the tissue samples tested. The assays indicated that the virus can be transmitted from porcine to human cells: in the specific case, infected NSK and NPTr cells allow passage to human 293 and MRC-5 cells with active production of the virus demonstrable via PCR and RT assay. In light of these aspects and also the lack of studies on PERVs, it appears clear that there are still many questions to be clarified, also by means of future studies, before xenotransplantation can be considered microbiologically safe.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"38-46"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis. 对同时感染 COVID-19 和肺曲霉菌病的病例进行分析。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Hui Zheng Hu, Li Bo Wu, Qian Liu, Bin Yan Wu, Yu Wang, Rui Ying Wang

The objective of this study was to investigate the risk factors and diagnosis measure of COVID-19-associated pulmonary aspergillosis (CAPA). This study included 201 COVID-19 patients from December 1, 2022, to January 31, 2023; 7 (3.5%) were diagnosed with CAPA. The main risk factors were age, MV, ICU admission and COPD, and the presence of comorbidities such as ARDS and hypoproteinemia in COVID-19 patients, more susceptible to Aspergillus infection. In addition to specimen culture in the lower respiratory tract, the 1,3-β-D-glucan antigen test can serve as an important screening indicator for early CAPA diagnosis in non-granulocytopenia patients.

本研究旨在探讨COVID-19相关肺曲霉菌病(CAPA)的风险因素和诊断措施。本研究纳入了2022年12月1日至2023年1月31日期间的201例COVID-19患者,其中7例(3.5%)被确诊为CAPA。主要风险因素为年龄、MV、入住ICU和COPD,COVID-19患者存在ARDS和低蛋白血症等合并症,更易感染曲霉菌。除下呼吸道标本培养外,1,3-β-D-葡聚糖抗原检测可作为非粒细胞减少症患者早期诊断 CAPA 的重要筛查指标。
{"title":"Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis.","authors":"Hui Zheng Hu, Li Bo Wu, Qian Liu, Bin Yan Wu, Yu Wang, Rui Ying Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The objective of this study was to investigate the risk factors and diagnosis measure of COVID-19-associated pulmonary aspergillosis (CAPA). This study included 201 COVID-19 patients from December 1, 2022, to January 31, 2023; 7 (3.5%) were diagnosed with CAPA. The main risk factors were age, MV, ICU admission and COPD, and the presence of comorbidities such as ARDS and hypoproteinemia in COVID-19 patients, more susceptible to Aspergillus infection. In addition to specimen culture in the lower respiratory tract, the 1,3-β-D-glucan antigen test can serve as an important screening indicator for early CAPA diagnosis in non-granulocytopenia patients.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"98-102"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Pneumonia Panel on laboratory samples from an Italian pediatric center: results from a monocentric study. 对意大利一家儿科中心实验室样本中的肺炎样本进行评估:单中心研究的结果。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Cristiana de Luca, Emanuela Gallo, Gabriella Tripepi, Ornella Leone

Lower respiratory tract infections (LRTI) are still burdened by considerable morbidity and mortality. Rapid and appropriate treatment imply knowledge of the underlying causative pathogen; while it is tempting to offer broad spectrum antibiotics, Antimicrobial Stewardship Practices invite a judicious use of the latter, especially when bacteria are not the cause. However, the epidemiology shifts to multidrug resistant (MDR) pathogens that require optimization of molecules in order to provide optimal treatment. Novel methods requiring direct sample result testing such as the Biofire Pneumonia (PN) panel have recently been made available on the market. Syndromic testing may hence provide support in the diagnosis of LRTI. There is paucity of data concerning experiences in high MDR settings, and even less concerning the performance of these panels in pediatric settings with moderate MDR prevalence. Our study highlights the optimal sensitivity and importance of support from such methods in settings burdened by MDR presence and where fast and appropriate therapy is mandatory.

下呼吸道感染(LRTI)的发病率和死亡率仍然很高。快速、适当的治疗意味着要了解潜在的致病病原体;虽然提供广谱抗生素很有诱惑力,但抗菌药物管理实践要求明智地使用后者,尤其是当细菌不是致病病原体时。然而,流行病学已转向耐多药(MDR)病原体,需要优化分子才能提供最佳治疗。最近市场上出现了需要直接进行样本结果检测的新方法,如 Biofire 肺炎(PN)检测面板。因此,综合检测可为 LRTI 的诊断提供支持。有关在高 MDR 环境中的经验的数据很少,而在中等 MDR 流行率的儿科环境中,有关这些面板性能的数据就更少了。我们的研究强调了在存在 MDR、必须进行快速和适当治疗的情况下,此类方法的最佳灵敏度和支持的重要性。
{"title":"Evaluation of the Pneumonia Panel on laboratory samples from an Italian pediatric center: results from a monocentric study.","authors":"Cristiana de Luca, Emanuela Gallo, Gabriella Tripepi, Ornella Leone","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lower respiratory tract infections (LRTI) are still burdened by considerable morbidity and mortality. Rapid and appropriate treatment imply knowledge of the underlying causative pathogen; while it is tempting to offer broad spectrum antibiotics, Antimicrobial Stewardship Practices invite a judicious use of the latter, especially when bacteria are not the cause. However, the epidemiology shifts to multidrug resistant (MDR) pathogens that require optimization of molecules in order to provide optimal treatment. Novel methods requiring direct sample result testing such as the Biofire Pneumonia (PN) panel have recently been made available on the market. Syndromic testing may hence provide support in the diagnosis of LRTI. There is paucity of data concerning experiences in high MDR settings, and even less concerning the performance of these panels in pediatric settings with moderate MDR prevalence. Our study highlights the optimal sensitivity and importance of support from such methods in settings burdened by MDR presence and where fast and appropriate therapy is mandatory.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"33-37"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tenofovir disoproxil fumarate in the treatment of COVID-19: Evaluation of 78 patients. 富马酸替诺福韦酯治疗 COVID-19:对 78 名患者的评估。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Gamze Şanlıdağ İşbilen, Isabel Raika Durusoy Onmuş, Ilkin Çankayalı, Kubilay Demirağ, Mehmet Uyar, Candan Çiçek, Tansu Yamazhan, Hüsnü Pullukçu, Oğuz Reşat Sipahi

One of the drugs that has been suggested for the treatment of SARS-CoV-2 infection is tenofovir disoproxil (TDF). Herein, it was aimed to evaluate the outcomes of TDF receiving COVID-19 cases in terms of day 7-10 PCR negativity and day 30 survival. Patients who received TDF due to PCR-confirmed COVID-19 between 27.04.2021 and 31.12.2021 were included in our study. The primary outcome was considered to be 7-10 days of PCR negativity, while the secondary outcome was considered 30-day survival after diagnosis of COVID-19. Patients who died before completing the treatment period (7-10 days) were also considered as PCR failures. Data were analyzed both in terms of intention to treat basis and in the subgroup that survived to the end of treatment. A total of 78 patients (30 women, mean age: 61.15±18.5 years) met the inclusion criteria. In the intention to treat analysis group, one-month-mortality was 44.87% (35/78) in the overall cohort. In the end of treatment analysis group, one-month-mortality was 29.5% (18/61) in the overall cohort. Day 7-10 PCR negativity was detected in 55.7% of the overall EOT cohort. Our data suggest that TDF may be an alternative salvage treatment option in antiviral unresponsive patients. We suggest evaluating TDF in well-designed controlled trials involving treatment-naïve cases.

治疗 SARS-CoV-2 感染的药物之一是替诺福韦酯(TDF)。本文旨在评估接受 TDF 治疗的 COVID-19 病例第 7-10 天 PCR 阴性率和第 30 天存活率。研究纳入了2021年4月27日至2021年12月31日期间因PCR确诊COVID-19而接受TDF治疗的患者。主要结果为 7-10 天 PCR 阴性,次要结果为确诊 COVID-19 后 30 天的存活率。在治疗期(7-10 天)结束前死亡的患者也被视为 PCR 失败。数据分析既以意向治疗为基础,也对治疗结束后存活的亚组进行了分析。共有 78 名患者(30 名女性,平均年龄:61.15±18.5 岁)符合纳入标准。在意向治疗分析组中,一个月死亡率为 44.87%(35/78)。在治疗结束分析组中,一个月死亡率为 29.5%(18/61)。在整个 EOT 组群中,第 7-10 天 PCR 阴性率为 55.7%。我们的数据表明,TDF可能是抗病毒无反应患者的另一种挽救治疗选择。我们建议在涉及治疗无效病例的设计良好的对照试验中对 TDF 进行评估。
{"title":"Tenofovir disoproxil fumarate in the treatment of COVID-19: Evaluation of 78 patients.","authors":"Gamze Şanlıdağ İşbilen, Isabel Raika Durusoy Onmuş, Ilkin Çankayalı, Kubilay Demirağ, Mehmet Uyar, Candan Çiçek, Tansu Yamazhan, Hüsnü Pullukçu, Oğuz Reşat Sipahi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>One of the drugs that has been suggested for the treatment of SARS-CoV-2 infection is tenofovir disoproxil (TDF). Herein, it was aimed to evaluate the outcomes of TDF receiving COVID-19 cases in terms of day 7-10 PCR negativity and day 30 survival. Patients who received TDF due to PCR-confirmed COVID-19 between 27.04.2021 and 31.12.2021 were included in our study. The primary outcome was considered to be 7-10 days of PCR negativity, while the secondary outcome was considered 30-day survival after diagnosis of COVID-19. Patients who died before completing the treatment period (7-10 days) were also considered as PCR failures. Data were analyzed both in terms of intention to treat basis and in the subgroup that survived to the end of treatment. A total of 78 patients (30 women, mean age: 61.15±18.5 years) met the inclusion criteria. In the intention to treat analysis group, one-month-mortality was 44.87% (35/78) in the overall cohort. In the end of treatment analysis group, one-month-mortality was 29.5% (18/61) in the overall cohort. Day 7-10 PCR negativity was detected in 55.7% of the overall EOT cohort. Our data suggest that TDF may be an alternative salvage treatment option in antiviral unresponsive patients. We suggest evaluating TDF in well-designed controlled trials involving treatment-naïve cases.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"47-51"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The presence of Trichomonas vaginalis in urogenital samples can affect the sensitivity of Mycoplasma hominis identification techniques, leading to an underestimation of bacterial infections. 泌尿系统样本中阴道毛滴虫的存在会影响人型支原体鉴定技术的灵敏度,导致低估细菌感染。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Valentina Margarita, Gavino Carboni, Pier Luigi Fiori, Paola Rappelli

Trichomonas vaginalis and Mycoplasma hominis, two microorganisms causing infections of the urogenital tract, are closely associated in that they establish an endosymbiosis relationship, the only case among human pathogens. As a result, the presence of one microorganism may be considered a sign that the other is present as well. Identification of the two pathogens in clinical samples is based on cultivation techniques on specific media, even though in recent years, new sensitive and rapid molecular techniques have become. Here, we demonstrate that the concomitant presence of T.vaginalis in urogenital swabs may lead to a delay in the identification of M.hominis, and thus to an underestimation of bacterial infections when cultural techniques are used.

阴道毛滴虫和人型支原体是导致泌尿生殖道感染的两种微生物,它们之间存在密切的共生关系,这在人类病原体中是绝无仅有的。因此,一种微生物的存在可被视为另一种微生物也存在的迹象。临床样本中这两种病原体的鉴定是基于特定培养基的培养技术,尽管近年来出现了新的灵敏、快速的分子技术。在这里,我们证明了泌尿生殖系统拭子中同时存在阴道球菌可能会导致人乳头瘤病毒的鉴定延迟,从而在使用培养技术时低估了细菌感染。
{"title":"The presence of Trichomonas vaginalis in urogenital samples can affect the sensitivity of Mycoplasma hominis identification techniques, leading to an underestimation of bacterial infections.","authors":"Valentina Margarita, Gavino Carboni, Pier Luigi Fiori, Paola Rappelli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Trichomonas vaginalis and Mycoplasma hominis, two microorganisms causing infections of the urogenital tract, are closely associated in that they establish an endosymbiosis relationship, the only case among human pathogens. As a result, the presence of one microorganism may be considered a sign that the other is present as well. Identification of the two pathogens in clinical samples is based on cultivation techniques on specific media, even though in recent years, new sensitive and rapid molecular techniques have become. Here, we demonstrate that the concomitant presence of T.vaginalis in urogenital swabs may lead to a delay in the identification of M.hominis, and thus to an underestimation of bacterial infections when cultural techniques are used.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"103-106"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and Clinical impact of single and multi-viral respiratory infections in post-pandemic era. 后流行病时代单一和多种病毒呼吸道感染的流行病学和临床影响。
IF 1.8 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-05-01
Maria Vittoria Mauro, Sonia Greco, Maura Pellegrini, Tommaso Campagna, Federica Caprino, Nadia Elia, Antonio Mastroianni, Francesca Greco

Acute respiratory tract infections (ARI) are common diseases in children and adults and could cause severe infections in high-risk patients, like the immunocompromised and elderly, and are the leading cause of morbidity, hospitalization and mortality. This study aimed to explore the prevalence of respiratory viruses and the clinical impact of single- and multi-infection among hospitalized patients in various age groups. 3578 nasopharyngeal swabs (NPS) were analyzed for pathogen detection of acute respiratory tract infections. 930 out of 3578 NPS were diagnosed positive for at least one respiratory virus. The distribution of viral infections, prevalence and pathogen, differed significantly among age groups. Most RTI are observed in the age group over 65 years (50.6%) with a high SARS-CoV2 prevalence, following by group <5 years (25.6%), where the most frequently detected viruses were RSV, Rhinovirus, FluA-H3, MPV, and AdV. The co-infection rate also varies according to age and, in some cases, especially in older adults, could have severe clinical impact. This study emphasizes that it is important to know and analyze, in all age groups of hospitalized patients, the epidemiology of respiratory viruses, the prevalence of coinfections, and the clinical impact of various pathogens. Furthermore, in a clinical setting, the rapid diagnosis of respiratory infections by means of molecular tests is crucial not only to avoid hospital outbreaks, but also to allow early and optimal treatment to reduce morbidity and mortality.

急性呼吸道感染(ARI)是儿童和成人的常见病,在免疫力低下和老年人等高危患者中可引起严重感染,是发病、住院和死亡的主要原因。本研究旨在探讨不同年龄组住院患者中呼吸道病毒的流行情况以及单次感染和多次感染对临床的影响。研究分析了 3578 份鼻咽拭子,以检测急性呼吸道感染的病原体。在 3578 份鼻咽拭子中,930 份被确诊为至少一种呼吸道病毒阳性。不同年龄组的病毒感染分布、流行率和病原体均有显著差异。大多数呼吸道感染发生在 65 岁以上的年龄组(50.6%),其 SARS-CoV2 感染率较高。
{"title":"Epidemiology and Clinical impact of single and multi-viral respiratory infections in post-pandemic era.","authors":"Maria Vittoria Mauro, Sonia Greco, Maura Pellegrini, Tommaso Campagna, Federica Caprino, Nadia Elia, Antonio Mastroianni, Francesca Greco","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Acute respiratory tract infections (ARI) are common diseases in children and adults and could cause severe infections in high-risk patients, like the immunocompromised and elderly, and are the leading cause of morbidity, hospitalization and mortality. This study aimed to explore the prevalence of respiratory viruses and the clinical impact of single- and multi-infection among hospitalized patients in various age groups. 3578 nasopharyngeal swabs (NPS) were analyzed for pathogen detection of acute respiratory tract infections. 930 out of 3578 NPS were diagnosed positive for at least one respiratory virus. The distribution of viral infections, prevalence and pathogen, differed significantly among age groups. Most RTI are observed in the age group over 65 years (50.6%) with a high SARS-CoV2 prevalence, following by group <5 years (25.6%), where the most frequently detected viruses were RSV, Rhinovirus, FluA-H3, MPV, and AdV. The co-infection rate also varies according to age and, in some cases, especially in older adults, could have severe clinical impact. This study emphasizes that it is important to know and analyze, in all age groups of hospitalized patients, the epidemiology of respiratory viruses, the prevalence of coinfections, and the clinical impact of various pathogens. Furthermore, in a clinical setting, the rapid diagnosis of respiratory infections by means of molecular tests is crucial not only to avoid hospital outbreaks, but also to allow early and optimal treatment to reduce morbidity and mortality.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 1","pages":"28-32"},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
New Microbiologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1